格隆汇8月12日丨磁谷科技(688448.SH)在投资者互动平台表示，液冷技术是一种利用液体作为传热介 质，通过循环流动直接或间接带走数据中心发热器件（如CPU、GPU等）热量的技术。不论是直接液冷 或间接液冷，都需要使用冷却系统对液冷传热介质进行冷却换热降温，才能使系统稳定运行。而磁悬浮 冷水机组是效率较高的一种冷却系统，能够大幅降低数据中心运行能耗。 ...

公告显示，磁谷科技本次拟投资建设磁悬浮压缩机及关联产品研发生产基地项目，旨在充分利用南京市 江宁开发区的优势资源，丰富公司磁悬浮压缩机相关产品种类，优化产品结构，加快推动公司在磁悬浮 流体机械领域的科技创新，进一步提升公司规模化生产能力和订单响应速度，从而增强公司的核心竞争 能力和未来整体盈利能力，促进公司长期可持续发展。 众和昆仑（北京）资产管理有限公司董事长柏文喜对《证券日报》记者表示："磁谷科技新项目重点布 局磁悬浮压缩机、ORC余热发电等高端机型，直接对标外资主力产品。这一举措与未来3年至5年内磁 悬浮压缩机核心技术突破方向高度契合。若能尽早完成可靠性认证，公司有望抢占下一轮技术制高点， 产品市场空间有望进一步打开。" 国际注册创新管理师、鹿客岛科技创始人兼CEO卢克林对《证券日报》记者表示："磁谷科技此次项目 把压缩机、ORC、真空、制冷打包，本质是将高速电机和轴承平台化，再叠加热力学优化和算法运 维，路线与行业主线完全同频。只要一期投产时同步上线远程诊断中心，就能把实验室技术直接转化为 客户现场的迭代数据，卡位非常精准。" 数据显示，2024年度磁谷科技实现营业收入4.78亿元。其中，磁悬浮空气产 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688448 证券简称：磁谷科技 公告编号：2025-028 南京磁谷科技股份有限公司 关于拟签署投资建设协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 拟投资项目名称：磁悬浮压缩机及关联产品研发生产基地项目 ● 协议对方名称：南京空港经济开发区（江宁）管理委员会 2、本次投资项目的实施尚需办理项目备案、环境影响评价、建设规划许可、施工许可等各项前置审批 工作，如因国家或地方有关政策调整、项目审批等实施条件发生变化，项目的实施可能存在延期、变更 或终止的风险。 3、本次投资项目的实施与市场供求、国家产业政策、行业竞争情况、公司管理及人才等因素密切相 关，上述任何因素的变动都可能对本项目的建设运营和预期效益带来不确定性。 4、《投资建设协议》中的项目投资金额、项目建设规模等数值均为预估数，项目实际投资金额、建设 规模等存在不确定性，并存在实际投资金额与项目投资计划产生差异的风险。协议中的投资金额并不代 表公司对未来业绩的 ...

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved an operating income of 4.258 billion yuan and a net profit of 1.123 billion yuan in the first half of 2025, with total comprehensive income of 1.106 billion yuan [3] - Shanghai Pudong Development Bank's net profit for the first half of 2025 was 29.737 billion yuan, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [6] - Xianhe Co. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [7] - Shengmei Shanghai reported a net profit of 696 million yuan for the first half of 2025, representing a year-on-year increase of 56.99% [14] Group 2: Regulatory and Corporate Actions - Sino Medical's subsidiary received breakthrough medical device designation from the FDA for its intracranial atherosclerosis treatment product, marking it as the first of its kind globally [2] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [8] - Tianyang Technology is planning to purchase equity in Tonglian Financial Services, with key transaction details still under negotiation [10] - Dongfang Guoxin's major shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [5] - Filinger's president reduced his holdings by 8,600 shares during a period of stock price volatility, while other executives did not sell shares [4]

Group 1: Company Performance - BeiGene reported a net profit of 450 million yuan for the first half of 2025, marking a turnaround from losses in the previous year, with product revenue increasing by 45.8% to 17.36 billion yuan and total revenue rising by 46.0% to 17.52 billion yuan [1] - CITIC Securities announced that Huaxia Fund achieved a net profit of 1.123 billion yuan in the first half of 2025, with total operating income of 4.258 billion yuan and total comprehensive income of 1.106 billion yuan [1] - Shanghai Pudong Development Bank reported a net profit of 29.737 billion yuan for the first half of 2025, reflecting a year-on-year growth of 10.19%, with total operating income of 90.559 billion yuan, up 2.62% [4] - Xianhe Co., Ltd. plans to invest approximately 11 billion yuan in a new integrated high-performance paper-based material project, with an expected annual output value of about 5.15 billion yuan from the first phase [5] - Shunbo Alloy reported a net profit growth of 110.56% year-on-year for the first half of 2025 [12] Group 2: Regulatory and Corporate Actions - Sino Medical announced that its subsidiary received breakthrough medical device designation from the FDA for a new intracranial atherosclerosis treatment product, marking a significant milestone as the first of its kind globally [1] - *ST Dongtong's actual controller and chairman is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6][7] - Tianyang Technology is planning to purchase equity in Tonglian Jinfu and related companies, with key transaction details still under negotiation [8] - Filinger reported stock price fluctuations, with the president reducing his holdings by 8,600 shares during a period of abnormal trading activity [2] - Dongfang Guoxin's controlling shareholder reduced their stake by 2.68 million shares, decreasing their total shareholding from 27.06% to 26.82% [3]

重要内容提示： 拟投资项目名称：磁悬浮压缩机及关联产品研发生产基地项目 协议对方名称：南京空港经济开发区（江宁）管理委员会 拟投资金额：项目拟投资总额 7 亿元，计划分两期开发建设，其中一期 项目计划投资额 3.05 亿元（该金额为预算金额，最终以实际投资金额为准）。 本次投资不涉及关联交易，亦不构成《上市公司重大资产重组管理办法》 《科创板上市公司重大资产重组特别规定》规定的重大资产重组。 相关风险提示： 证券代码：688448 证券简称：磁谷科技 公告编号：2025-028 南京磁谷科技股份有限公司 关于拟签署投资建设协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 1、本次投资项目所涉及的项目用地需按照国家现行法律法规及正常规定的 用地程序办理，需根据法定"招、拍、挂"程序取得建设用地。本项目投资、实施 是以公司竞得项目用地为前提，土地使用权能否竞得、土地使用权的最终成交面 积、价格及取得时间存在不确定性。 2、本次投资项目的实施尚需办理项目备案、环境影响评价、建设规划许可、 施工许可等各项 ...

Group 1 - Fengcai Technology is conducting an H-share issuance with a maximum price of 120.50 HKD per share, aiming to raise funds for its specialized chip business [1] - The global offering consists of 16.3 million shares, with 1.63 million shares available for public offering in Hong Kong [1] - Zijin Mining plans to acquire the Raygorodok gold mine project in Kazakhstan for 1.2 billion USD, enhancing its resource portfolio [1][2] Group 2 - Mindray Medical's shareholder plans to reduce holdings by up to 5 million shares, approximately 0.41% of the total share capital, due to personal funding needs [3] - Degute is planning to acquire control of Haowei Technology through a combination of cash and share issuance, leading to a temporary suspension of its stock [4] - New Dairy's controlling shareholder intends to reduce its stake by up to 3% of the total share capital, also for funding purposes [5] Group 3 - Yueyang Xinchang has resumed production after completing maintenance on its main production facilities, positively impacting its operations [6] - Chengdu Xian Dao has terminated its major asset restructuring plan due to failure to reach agreement on key terms [7] - Maglev Technology's shareholder plans to reduce its stake by up to 3% of the total share capital for personal financial arrangements [9] Group 4 - Zhongyan Dadi announced a cash dividend of 2.82 CNY per 10 shares and a capital increase of 3.99 shares per 10 shares [10] - Yunda Co. plans to distribute a cash dividend of 0.6 CNY per 10 shares, totaling approximately 47.22 million CNY [12] - Victory Co. intends to distribute a cash dividend of 0.42 CNY per 10 shares, amounting to around 36.06 million CNY [13] Group 5 - Shagang Group has invested 2.67 billion CNY in financial products while planning to use up to 8 billion CNY of idle funds for further investments [14] - Jiuyuan Yinhai's subsidiary won an 8.43 million CNY project contract, constituting a related party transaction [15] - China Railway Signal & Communication has announced the resignation of a board member due to personal reasons [16] Group 6 - China Rare Earth clarified that recent management changes have not affected its operations, ensuring stability in production [17] - Qixiang Tengda plans to conduct routine maintenance on its 60,000-ton acetone plant for 60 days to enhance operational safety [19] - ST King Kong's subsidiary signed a 399 million CNY contract for computing power services, indicating growth in its service offerings [20] Group 7 - Ziguang Guowei repurchased 775,500 shares for approximately 49.62 million CNY, reflecting confidence in its market position [22] - Qin Port's major shareholder plans to reduce its stake by up to 2% of the total share capital for development needs [22] - Longqi Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, expanding its market presence [24]

Group 1 - The major shareholder, Nanjing Baolifeng Venture Capital Partnership, plans to reduce its stake in Magu Technology by up to 2,149,569 shares, representing 3.00% of the total share capital [1][2] - The reduction will occur through centralized bidding and block trading, with a maximum of 716,523 shares (1.00%) through centralized bidding and 1,433,046 shares (2.00%) through block trading [1] - The reduction period is set for three months starting from 15 trading days after the announcement, with specific limits on the number of shares that can be sold within any 90-day period [1] Group 2 - As of the announcement date, Baolifeng holds 8,092,500 shares, accounting for 11.29% of the total share capital, with some shares already listed for trading [2] - The total shares held by Baolifeng and its concerted action person, Dong Jiyong, amount to 10,522,500 shares, representing 14.69% of the total share capital [2] - The reduction is described as a normal behavior based on the shareholder's needs and is not expected to significantly impact the company's governance structure or ongoing operations [2] Group 3 - Magu Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 21, 2022, with an issuance of 17.8153 million shares at a price of 32.90 yuan per share [3] - The total funds raised from the issuance amounted to 585.1234 million yuan, with a net amount of 528.5685 million yuan after deducting issuance costs [3] - The company plans to use the raised funds for the production of efficient intelligent integrated magnetic suspension fluid equipment, R&D center construction, and to supplement working capital [3]

Core Viewpoint - The major shareholder, Nanjing Baolifeng Venture Capital Partnership, plans to reduce its stake in Nanjing Magu Technology Co., Ltd. by up to 2,149,569 shares, representing a maximum of 3.00% of the total share capital, due to personal financial arrangements [2][3]. Shareholder Holding Situation - As of the announcement date, Nanjing Baolifeng holds 8,092,500 shares, accounting for 11.29% of the total share capital, with 1,232,500 shares already tradable since September 21, 2023, and 6,860,000 shares becoming tradable on March 21, 2024 [1]. - The company's director and general manager, Dong Jiyong, holds 2,430,000 shares, representing 3.39% of the total share capital, with 2,400,000 shares from pre-IPO holdings and 30,000 shares from equity incentives [1]. Reduction Plan Details - The reduction plan includes a maximum of 716,523 shares through centralized bidding and 1,433,046 shares through block trading, with the reduction period starting 15 trading days after the announcement [2][3]. - The total number of shares to be reduced during the reduction period will not exceed 1% of the total shares, and for block trading, it will not exceed 2% within any 90 consecutive days [2][3]. Previous Reduction Activities - In the past 12 months, Nanjing Baolifeng reduced its holdings by 97,500 shares, which is 0.14% of the total shares, at a price of 36.20 yuan per share [3].

Group 1 - Longqi Technology has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [1] - Chengdu XianDao has terminated the acquisition of approximately 65% equity in Nanjing Haina Pharmaceutical Technology Co., Ltd. due to failure to reach consensus on core terms [4] - Unigroup Guowei repurchased 775,500 shares for a total amount of 49.6173 million yuan on June 27 [5] Group 2 - Qinhuangdao State-owned Assets Supervision and Administration Commission plans to reduce its stake in Qin Port Co., Ltd. by up to 2% [2] - Magu Technology's shareholder Baolifeng intends to reduce its stake by up to 3% [3] - New Dairy's controlling shareholder plans to reduce its stake by up to 3% due to funding needs [6] Group 3 - Mindray Medical's shareholder EverUnion (H.K.) Limited plans to reduce its stake by up to 500,000 shares, representing approximately 0.41% of the total share capital [7] - Degute plans to acquire control of Haowei Technology, with trading suspended from June 30 [8]